You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

STAT3 Mutation

Showing 1 - 25 of 7,470
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Refractory Tumor Trial in Dallas, San Antonio (DCR-STAT3)

Recruiting
  • Solid Tumor, Adult
  • Refractory Tumor
  • Dallas, Texas
  • +1 more
Oct 21, 2023

Genetics of Hyperimmunoglobulin E Recurrent Infection Syndrome

Recruiting
  • Infections
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Investigating STAT3 as a Driver of Pathology in Periodontitis

    Recruiting
    • Periodontitis
    • no intervention
    • Santiago, Chile
      Faculty of Dentistry, University of Chile
    Aug 16, 2022

    Genetic Analysis of Immune Disorders

    Recruiting
    • DOK 8
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 27, 2023

      Novel Genetic Disorders of the Immune System

      Recruiting
      • PI3KCD
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

        Not yet recruiting
        • Pancreatic Ductal Adenocarcinoma
        • Miami, Florida
          University of Miami
        Jun 27, 2022

        Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

        Recruiting
        • Advanced Malignant Solid Neoplasm
        • +9 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 25, 2022

        Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer Trial in Atlanta, Houston, San Antonio

        Recruiting
        • Breast Cancer
        • +7 more
        • Atlanta, Georgia
        • +2 more
        Jun 13, 2022

        Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)

        Not yet recruiting
        • Head and Neck Squamous Cell Carcinoma
        • (no location specified)
        Dec 20, 2022

        Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

        Not yet recruiting
        • Acute Myeloid Leukemia With FLT3/ITD Mutation
        • (no location specified)
        May 24, 2023

        Patterns Among PIK3CA Mutation in Advanced Breast Cancer

        Completed
        • Breast Cancer
          • East Hanover, New Jersey
            Novartis
          Aug 1, 2023

          Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)

          Recruiting
          • Brain Tumor
          • +2 more
          • Atlanta, Georgia
            Children's Healthcare of Atlanta (CHOA)
          Jul 24, 2022

          Lymphatic Malformations Trial (Alpelisib, Placebo)

          Not yet recruiting
          • Lymphatic Malformations
          • (no location specified)
          Jul 4, 2023

          NSCLC Metastatic Trial in Stockholm (Stereotactic body radiation therapy (SBRT), Temporary Stopping)

          Recruiting
          • Non-small Cell Lung Cancer Metastatic
          • Stereotactic body radiation therapy (SBRT)
          • Temporary Stopping
          • Stockholm, Solna, Sweden
            Karolinska University Hospital
          Nov 9, 2023

          Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

          Recruiting
          • Metastatic Solid Tumor
          • +4 more
          • Recommendation for treatment with immunotherapy
          • Baltimore, Maryland
            Johns Hopkins University
          Sep 8, 2022

          NSCLC Trial (Idylla EGFR_IUO/3.20 Mutation Test)

          Not yet recruiting
          • NSCLC
          • Idylla EGFR_IUO/3.20 Mutation Test
          • (no location specified)
          Jul 24, 2023

          3L+ Therapies Among Chronic Myeloid Leukemia and Those With

          Completed
          • Chronic Myeloid Leukemia
            • East Hanover, New Jersey
              Novartis Investigative Site
            Nov 11, 2022

            Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

            Active, not recruiting
            Has Results
            • Chronic Lymphocytic Leukemia
            • Small Lymphocytic Leukemia
            • Boston, Massachusetts
            • +1 more
            Nov 14, 2022

            Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

            Active, not recruiting
            • Advanced Cancers
            • Solid Tumors
            • Houston, Texas
              University of Texas MD Anderson Cancer Center
            Dec 16, 2022

            Xospata in Relapsed or Refractory Acute Myeloid Leukemia With

            Recruiting
            • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
            • Gilteritinib Exposure
            • Goyang-si, Gyeonggi-do, Korea, Republic of
            • +4 more
            Aug 18, 2022

            Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

            Not yet recruiting
            • Triple Negative Breast Cancer
            • +2 more
            • Shanghai, Shanghai, China
              Fudan University Shanghai Cancer Center
            Jul 25, 2023

            Hypertrophic Cardiomyopathy Trial in United States (TN-201)

            Not yet recruiting
            • Hypertrophic Cardiomyopathy
            • TN-201
            • Boston, Massachusetts
            • +6 more
            Apr 18, 2023

            A NIS of Alpelisib in Combination With Fulvestrant in

            Not yet recruiting
            • Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
            • Alpelisib
            • Fulvestrant
            • (no location specified)
            Aug 9, 2022

            KRAS P.G12C Trial in Worldwide (D3S-001)

            Recruiting
            • KRAS P.G12C
            • Detroit, Michigan
            • +12 more
            Jan 16, 2023

            Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

            Recruiting
            • Advanced Breast Cancer
            • Thalassery, Kerala, India
              Novartis Investigative Site
            Nov 21, 2022